Moa Life Plus

Moa Life Plus Current Liabilities

The Current Liabilities of Moa Life Plus (142760.KQ) as of Oct 30, 2026 is 140.93 M KRW. In the previous year, Current Liabilities was 15.22 B KRW — a change of -99.07% (lower).

Current Liabilities

140.93 MKRW

YoY

-99.07%

Last updated:

Current Liabilities of Moa Life Plus is 2025 140.93 M KRW. Current Liabilities of Moa Life Plus was 2024 15.22 B KRW. It decreases by -99.07% lower compared to the previous year.

The Moa Life Plus Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
78.36 B KRW
Jan 1, 2019
62.84 B KRW
Jan 1, 2020
63.27 B KRW
Jan 1, 2021
46.70 B KRW
Jan 1, 2022
64.97 B KRW
Jan 1, 2023
7.68 B KRW
Jan 1, 2024
15.22 B KRW
Jan 1, 2025
140.93 M KRW
The Moa Life Plus Current Liabilities history
YEARCurrent LiabilitiesYoY
140.93 MKRW-99.07%
15.22 BKRW+98.14%
7.68 BKRW-88.18%
64.97 BKRW+39.13%
46.70 BKRW-26.19%
63.27 BKRW+0.68%
62.84 BKRW-19.81%
78.36 BKRW+3,933.31%
1.94 BKRW-39.25%
3.20 BKRW+280.68%
840.00 MKRW-82.23%
4.73 BKRW-43.03%
8.30 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Moa Life Plus Stock analysis

What does Moa Life Plus do? BL Corp. develops biopharmaceutical products and manufactures health functional foods and functional cosmetics. The company distributes Glu 100 Tablets, CellribonQ, and GentaQ to general hospitals and pharmacies. It generates revenue through the sale of these pharmaceuticals and health-related products to healthcare providers and retail outlets. The firm's product portfolio includes Glu 100 Tablets, CellribonQ, and GentaQ, which are distributed to general hospitals and pharmacies. These products are sold as part of the company's pharmaceutical and medical supplies distribution business. Revenue is derived from the sale of these branded medicines and health functional products. BL Corp. focuses on the distribution of specific branded pharmaceuticals and health functional products. The company's primary customers are general hospitals and pharmacies, which purchase Glu 100 Tablets, CellribonQ, and GentaQ for resale or direct use in healthcare settings. Moa Life Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moa Life Plus stock

Current Liabilities of Moa Life Plus is 140.93 M KRW in 2025.

Current Liabilities of Moa Life Plus changed from 15.22 B KRW to 140.93 M KRW, representing a -99.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Moa Life Plus since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Moa Life Plus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Moa Life Plus

All Key Metrics — Moa Life Plus